Methohexital

Generic Name
Methohexital
Brand Names
Brevital
Drug Type
Small Molecule
Chemical Formula
C14H18N2O3
CAS Number
151-83-7
Unique Ingredient Identifier
E5B8ND5IPE
Background

An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.

Indication

诱导麻醉。

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction of anesthesia therapy, Sedative therapy

Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2022-12-19
Last Posted Date
2024-03-13
Lead Sponsor
Medical University of Vienna
Target Recruit Count
100
Registration Number
NCT05655754
Locations
🇦🇹

Pia Baldinger-Melich, Vienna, Austria

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

First Posted Date
2019-12-05
Last Posted Date
2023-11-13
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
73
Registration Number
NCT04187196
Locations
🇺🇸

Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

EEG Characteristics in ECT

First Posted Date
2019-07-17
Last Posted Date
2024-10-26
Lead Sponsor
University of New Mexico
Target Recruit Count
11
Registration Number
NCT04022226
Locations
🇺🇸

University of New Mexico Mental Health Center, Albuquerque, New Mexico, United States

Ketamine Anesthesia for Improvement of Depression in ECT

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-04-27
Last Posted Date
2018-06-06
Lead Sponsor
VA Puget Sound Health Care System
Target Recruit Count
52
Registration Number
NCT02752724
Locations
🇺🇸

VA Puget Sound Health Care System, Seattle, Washington, United States

Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-12-08
Last Posted Date
2019-03-13
Lead Sponsor
Milton S. Hershey Medical Center
Target Recruit Count
51
Registration Number
NCT02624050
Locations
🇺🇸

Penn State Milton S Hershey Medical Ctr, Hershey, Pennsylvania, United States

Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression

First Posted Date
2013-07-24
Last Posted Date
2018-11-14
Lead Sponsor
St Patrick's Hospital, Ireland
Target Recruit Count
138
Registration Number
NCT01907217
Locations
🇮🇪

St Patrick's University Hospital, Dublin, Ireland

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

First Posted Date
2013-06-20
Last Posted Date
2023-03-09
Lead Sponsor
Northwell Health
Target Recruit Count
31
Registration Number
NCT01881763
Locations
🇺🇸

Zucker Hillside Hospital, Glen Oaks, New York, United States

Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2012-03-30
Last Posted Date
2014-12-30
Lead Sponsor
University of New Mexico
Target Recruit Count
20
Registration Number
NCT01567852
Locations
🇺🇸

University of New Mexico, Albuquerque, New Mexico, United States

Ketamine Anesthesia in Electroconvulsive Therapy

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-06-06
Last Posted Date
2013-08-08
Lead Sponsor
Mayo Clinic
Target Recruit Count
38
Registration Number
NCT01367119
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2011-03-07
Last Posted Date
2013-08-30
Lead Sponsor
James Murrough
Target Recruit Count
3
Registration Number
NCT01309581
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York City, New York, United States

© Copyright 2024. All Rights Reserved by MedPath